Application of Contrast‐Enhanced Ultrasound Parameters of Metastatic Axillary Lymph Nodes in Breast Cancer Patients in Predicting the Efficacy of Neoadjuvant Chemotherapy in Early Stage
Journal of Clinical Ultrasound · 2025
DOI: 10.1002/jcu.23922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Ultrasound, 2025. Verfasst von Jiawei Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Inpatient Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Contrast Media, Lymph Nodes. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Fundamental Research Funds for the Provincial Universities of Heilongjiang, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
To investigate the performance of contrast‐enhanced ultrasound(CEUS) parameters of metastatic axillary lymph nodes (ALNs) before and after two courses of neoadjuvant chemotherapy (NAC) in breast cancer patients in predicting the efficacy of NAC.
Methods
A total of 41 postoperative breast cancer patients were selected. All patients underwent NAC, and ALN biopsy was positive before chemotherapy. Metastatic ALN was examined by CEUS before and after two courses of NAC. The CEUS parameters of metastatic ALNs before and after two courses of NAC were analyzed to determine the performance of CEUS parameters in predicting the efficacy of NAC in early stage.
Results
The NAC was effective for 28 cases and ineffective for 13 cases. There were no statistically significant differences in the CEUS parameters between effective NAC and ineffective NAC individuals before and after two courses of NAC. But, there were statistically significant differences in long diameter (LD), short diameter (SD), Peak intensity (Peak%) and area under the curve (AUC) between the effective and ineffective NAC patients after two courses of NAC. Receiver operating characteristic curve (ROC) analysis suggested the drop‐out value of LD, SD, Peak% and AUC after two courses of NAC can be used as important indicators to evaluate the efficacy of NAC ( p < 0.05).
Conclusions
CEUS parameters of metastatic axillary lymph nodes (ALNs) before and after two courses of neoadjuvant chemotherapy (NAC) in breast cancer patients can predict the efficacy of NAC in early stage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inpatient Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Health Record Management, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
ORCID-Profile: Jiawei Sun, Xianli Zhou
Förderung
- Fundamental Research Funds for the Provincial Universities of Heilongjiang
- National Natural Science Foundation of China
Zitieren
APA
Sun, J., Zhao, Q., He, Y., & Zhou, X. (2025). Application of Contrast‐Enhanced Ultrasound Parameters of Metastatic Axillary Lymph Nodes in Breast Cancer Patients in Predicting the Efficacy of Neoadjuvant Chemotherapy in Early Stage. Journal of Clinical Ultrasound. https://doi.org/10.1002/jcu.23922
Vancouver
Sun J, Zhao Q, He Y, Zhou X. Application of Contrast‐Enhanced Ultrasound Parameters of Metastatic Axillary Lymph Nodes in Breast Cancer Patients in Predicting the Efficacy of Neoadjuvant Chemotherapy in Early Stage. Journal of Clinical Ultrasound. 2025. doi:10.1002/jcu.23922
BibTeX
@article{Sun2025,
author = {Sun, Jiawei and Zhao, Qingzhuo and He, Yan and Zhou, Xianli},
title = {Application of Contrast‐Enhanced Ultrasound Parameters of Metastatic Axillary Lymph Nodes in Breast Cancer Patients in Predicting the Efficacy of Neoadjuvant Chemotherapy in Early Stage},
journal = {Journal of Clinical Ultrasound},
year = {2025},
doi = {10.1002/jcu.23922}
}
EUVIMED